The relationship between Noggin (NOG) and methylenetetrahydrofolate reductase and nonsyndromic cleft lip and palate (NSCLP) has been reported participate in craniofacial development but need further evidence. To indicate the susceptibility between the 2 genes and NSCLP, rs227731 and rs1801131 polymorphisms were included in the present research. This research may provide some genetic clues for disease detection and surveillance.
Design:
Seventeen studies including 4023 cases and 5691 controls were provided for meta-analysis, and odds ratio (OR) with 95% CI were obtained to estimate NSCLP risk.
Results:
Our analysis suggested potential association of rs227731C on increasing the risk of NSCLP in the Caucasian group and total group but not Asian group under all models: allele (OR = 1.45, 95% CI = 1.21-1.75, P < .0001), homozygote (OR = 2.03, 95% CI = 1.42-2.90, P < .0001), heterozygote (OR = 1.44, 95% CI = 1.19-1.73, P = .0001), dominant (OR = 1.61, 95% CI = 1.27-2.04, P < .0001), and recessive models (OR = 1.63, 95% CI = 1.25-2.12, P = .0003). Besides, increased risk is related to rs1801131 in Asian group under 3 models: allele (OR = 1.24, 95% CI = 1.06-1.44, P = .006), heterozygote (OR = 1.24, 95% CI = 1.02-1.52, P = .03), and dominant models (OR = 1.29, 95% CI = 1.06-1.56, P = .009).
Conclusions:
Our analysis indicates polymorphisms rs227731 and rs1801131 are associated with NSCLP, with predominance of different ethnic group and deepen understanding of NSCLP.
AfzalSJensenSAVainerBVogelUMatsenJPSørensenJBAndersenPKPoulsenHE. MTHFR polymorphisms and 5-FU-based adjuvant chemotherapy in colorectal cancer. Ann Oncol. 2009;20(10):1660–1666.
2.
CarinciFPalmieriAScapoliLCuraFBorelliFMorselliPGNouriNAbdaliHGianniABRussilloA, et al.Non-syndromic cleft palate: association analysis on three gene polymorphisms of the folate pathway in Asian and Italian populations. Int J Immunopathol Pharmacol. 2019;33:2058738419858572:1–5.
3.
CorreaAGilboaSMBesserLMBottoLDMooreCAHobbsCAClevesMARiehle-ColarussoTJWallerDKReeceEA, et al.Diabetes mellitus and birth defects. Am J Obstet Gynecol. 2008;199(3):237 e23–239.
4.
CuraFBohmerACKlamtJSchünkeHScapoliLMartinelliMCarinciFNöthenMMKnappMLudwigKU, et al.Replication analysis of 15 susceptibility loci for nonsyndromic cleft lip with or without cleft palate in an Italian population. Birth Defects Res A Clin Mol Teratol. 2016;106(3):81–87.
5.
DavalbhaktaAHallPN. The impact of antenatal diagnosis on the effectiveness and timing of counselling for cleft lip and palate. Br J Plast Surg. 2000;53(4):298–301.
6.
de AguiarPKColettaRDde OliveiraAMMachadoRAFurtadoPGde OliveiraLAde AquinoSNJuniorHMde Almeida ReisSRMoreiraHS, et al.rs1801133C>T polymorphism in MTHFR is a risk factor for nonsyndromic cleft lip with or without cleft palate in the Brazilian population. Birth Defects Res A Clin Mol Teratol. 2015;103(4):292–298.
7.
DesaiALDineshMRAmarnathBCDharmaRMAkshaiKRPrashanthCS. Association of transforming growth factor alpha and methylenetetrahydrofolate reductase gene variants with nonsyndromic cleft lip and palate in the Indian population. Contemp Clin Dent. 2014;5(3):329–333.
8.
DixonMJMarazitaMLBeatyTHMurrayJC. Cleft lip and palate: understanding genetic and environmental influences. Nat Rev Genet. 2011;12(3):167–178.
9.
FrosstPBlomHJMilosRGoyettePSheppardCAMatthewsRGBoersGJDen HeijerMKluijtmansLAVan Den HeuveLP, et al.A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10(1):111–113.
10.
GoyettePSumnerJSMilosRDuncanAMRosenblattDSMatthewsRGRozenR. Human methylenetetrahydrofolate reductase: isolation of cDNA mapping and mutation identification. Nat Genet. 1994;7(2):195–200.
11.
HasanzadehNKhodaMOJahanbinAVatankhahM. Coping strategies and psychological distress among mothers of patients with nonsyndromic cleft lip and palate and the family impact of this disorder. J Craniofac Surg. 2014;25(2):441–445.
12.
HoneinMARasmussenSAReefhuisJRomittiPALammerEJSunLCorreaA. Maternal smoking and environmental tobacco smoke exposure and the risk of orofacial clefts. Epidemiology. 2007;18(2):226–233.
13.
KerameddinSNamipashakiAEbrahimiSAnsari-PourN. IRF6 Is a marker of severity in nonsyndromic cleft lip/palate. J Dent Res. 2015;94(9 suppl):226S–232S.
14.
LeslieEJCarlsonJCShafferJRButaliABuxóCJCastillaEEChristensenKDeleyiannisFWFieldLLHechtJT, et al.Genome-wide meta-analyses of nonsyndromic orofacial clefts identify novel associations between FOXE1 and all orofacial clefts, and TP63 and cleft lip with or without cleft palate. Hum Genet. 2017;136(3):275–286.
15.
LeslieEJTaubMALiuHSteinbergKMKoboldtDCZhangQCarlsonJCHetmanskiJBWangHLarsonDE, et al.Identification of functional variants for cleft lip with or without cleft palate in or near PAX7, FGFR2, and NOG by targeted sequencing of GWAS loci. Am J Hum Genet. 2015;96(3):397–411.
16.
MangoldELudwigKUBirnbaumSBaluardoCFerrianMHermsSReutterHde AssisNAAl ChawaTMattheisenM, et al.Genome-wide association study identifies two susceptibility loci for nonsyndromic cleft lip with or without cleft palate. Nat Genet. 2010;42(1):24–26.
17.
MargulisAVMitchellAAGilboaSMWerlerMMMittlemanMAGlynnRJHernandez-DiazSStudyNB. Use of topiramate in pregnancy and risk of oral clefts. Am J Obstet Gynecol. 2012;207(5):405e1–e7.
18.
MitchellLE. Genetic epidemiology of birth defects: nonsyndromic cleft lip and neural tube defects. Epidemiol Rev. 1997;19(1):61–68.
19.
MorenoLMMansillaMABullardSACooperMEBuschTDMachidaJJohnsonMKBrauerDKrahnKDaack-HirschS, et al.FOXE1 association with both isolated cleft lip with or without cleft palate, and isolated cleft palate. Hum Mol Genet. 2009;18(24):4879–4896.
20.
MosseyPALittleJMungerRGDixonMJShawWC. Cleft lip and palate. Lancet. 2009;374(9703):1773–1785.
21.
MostowskaAHozyaszKKWojcickaKBiedziakBJagodzinskiPP. Polymorphic variants at 10q25.3 and 17q22 loci and the risk of non-syndromic cleft lip and palate in the polish population. Birth Defects Res A Clin Mol Teratol. 2012;94(1):42–46.
22.
PanYMaJZhangWWangYWangYZhangHWangMZhangZWangL. Replication of two novel susceptibility loci for non-syndromic orofacial clefts in a Chinese population. Oral Dis. 2011;17(3):304–308.
23.
ParkerSEMaiCTCanfieldMARickardRWangYMeyerREAndersonPMasonCACollinsJSKirbyRS, et al.Updated national birth prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol. 2010;88(12):1008–1016.
24.
Rey-BelletCHohlfeldJ. Prenatal diagnosis of facial clefts: evaluation of a specialised counselling. Swiss Med Wkly. 2004;134(43-44):640–644.
25.
SalagovicJKlimcakovaLZabavnikovaMBehunovaJHudakovaTFedelesJMolnarovaAPodrackaL. Polymorphisms at 1q32, 8q24, and 17q22 loci are associated with nonsyndromic cleft lip with or without cleft palate risk in the Slovak population. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017;161(2):152–157.
26.
SchroderHCPerovic-OttstadtSWiensMBatelRMullerIMMullerWE. Differentiation capacity of epithelial cells in the sponge suberites domuncula. Cell Tissue Res. 2004;316(2):271–280.
27.
SchwabMZangerUMMarxCSchaeffelerEKleinKDipponJKerbRBlievernichtJFischerJHofmannU, et al.Role of genetic and nongenetic factors for fluorouracil treatment-related severe toxicity: a prospective clinical trial by the German 5-FU toxicity study group. J Clin Oncol. 2008;26(13):2131–2138.
28.
SpeltzMLArmsdenGCClarrenSS. Effects of craniofacial birth defects on maternal functioning postinfancy. J Pediatr Psychol. 1990;15(2):177–196.
29.
SullJWLiangKYHetmanskiJBFallinMDIngersollRGParkJWu-ChouYHChenPKChongSSCheahF, et al.Maternal transmission effects of the PAX genes among cleft case-parent trios from four populations. Eur J Hum Genet. 2009;17(6):831–839.
30.
SuzukiSMarazitaMLCooperMEMiwaNHingAJugessurANatsumeNShimozatoKOhbayashiNSuzukiY, et al.Mutations in BMP4 are associated with subepithelial, microform, and overt cleft lip. Am J Hum Genet. 2009;84(3):406–411.
31.
TolarovaMMCervenkaJ. Classification and birth prevalence of orofacial clefts. Am J Med Genet. 1998;75(2):126–137.
32.
van der PutNMGabreelsFStevensEMSmeitinkJATrijbelsFJEskesTKvan den HeuvelLPBlomHJ. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?Am J Hum Genet. 1998;62(5):1044–1051.
33.
van RooijIALMVermeij-KeersCKluijtmansLAOckéMCZielhuisGAGoorhuis-BrouwerSMvan der BiezenJJKuijpers-JagtmanAMSteegers-TheunissenRP. Does the interaction between maternal folate intake and the methylenetetrahydrofolate reductase polymorphisms affect the risk of cleft lip with or without cleft palate?Am J Epidemiol. 2003;157(7):583–591.
34.
WangHHuCXiaoSHWanB. Association of tagging SNPs in the MTHFR gene with risk of type 2 diabetes mellitus and serum homocysteine levels in a Chinese population. Dis Markers. 2014;2014:7257311:1–6.
35.
WiemelsJLSmithRNTaylorGMEdenOBAlexanderFEGreavesMF, United Kingdom Childhood Cancer Study investigators. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci U S A. 2001;98(7):4004–4009.
36.
WongFKHaggU. An update on the aetiology of orofacial clefts. Hong Kong Med J. 2004;10(5):331–336.
37.
WorleyMLPatelKGKilpatrickLA. Cleft lip and palate. Clin Perinatol. 2018;45(4):661–678.
38.
ZhangZSongYZhaoXZhangXFerminCChenY. Rescue of cleft palate in Msx1-deficient mice by transgenic Bmp4 reveals a network of BMP and Shh signaling in the regulation of mammalian palatogenesis. Development. 2002;129(17):4135–4146.
39.
ZhouBSBuGYLiMChangBGZhouYP. Tagging SNPs in the MTHFR gene and risk of ischemic stroke in a Chinese population. Int J Mol Sci. 2014;15(5):8931–8940.
